EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Efficacy and Safety of Modified Double-snare-assisted Endoscopic Mucosal Resection for Small Rectal Neuroendocrine Tumours: A Preliminary Study

Xiwei Ding, Tianlu Huang, Fan Zhou, Supeng Wang, Wei Zhang, Nina Zhang, Liangliang Shi, Dehua Tang, Ying Lv, Lei Wang

Endoscopy International Open · 2026-10-12 · 14 (CP)

DOI: 10.1055/a-2938-5538 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Modified double-snare-assisted endoscopic mucosal resection (mDS-EMR) through single-channel endoscopy has been reported as a promising technique for treating rectal neuroendocrine tumours (NETs). We evaluated the efficacy and safety of mDS-EMR for small rectal NETs. Methods This retrospective study included consecutive patients who underwent mDS-EMR between January 2025 and December 2025 at a single centre. Clinical data and therapeutic outcomes were analysed. Results Thirty-five patients with 38 rectal NETs were included. The median lesion size was 5 mm (range: 1–13 mm). The technical success rate was 100%. R0 resection was achieved in 37 out of 38 lesions (97.4%), including the largest lesion. The 95% confidence interval for R0 resection rate is 86.5–99.5%. The en bloc resection rate was 97.4%. The median resection time was 2.5 min per lesion (range: 1–9 minutes). The delayed bleeding rate was 2.6% (one patient). Perforation did not occur during or after the procedure. The median length of hospital stay after the procedure was 2 days (range: 0–5 days). The median cost of the device used for mDS-EMR is $237.4 (range: $186.7–537.2). Conclusions mDS-EMR appeared to be a safe, and effective method for resecting small rectal NETs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →